Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Storage Lyophilized (unreconstituted): Store at -20C for long-term stability
Distribution Channel Segment Analysis The hospital pharmacies segment, which is part of the distribution channel, is expected to garner the third-largest share in the semaglutide market by the end of the stipulated period
Oral Non Peptide GLP 1 Receptor Agonist Market is segmented into Type, Application, Distribution Channel, and By Region Novo Nordisk A/S, Eli Lilly and Company, Pfizer Inc., Roche Holding AG, Structure Therapeutics Inc., Amgen Inc., Viking Therapeutics Inc., AstraZeneca PLC, Boehringer Ingelheim, Merck & Co., Inc., Carmot Therapeutics, Sciwind Biosciences, Hanmi Pharmaceutical, Metsera Inc., Regor Therapeutics Group, Chugai Pharmaceutical Co., Ltd., Zealand Pharma A/S, Altimmune Inc., Innovent Biologics Inc., and Jiangsu Hengrui Pharmaceuticals
Tak YJ, Shin DK, Kim AH, Kim JI, Lee YL, Ko H-C, et al
Despite the generally non-severe nature of these incidents, people were seeking emergency care at much higher rates
US$ 28.41
US$ 24.98
US$ 26.64
US$ 20.55
US$ 24.39
